Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al.
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2023.11.005 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Jean M Connors und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: jconnors@bwh.harvard.edu. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: jconnors@bwh.harvard.edu.
- Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. Electronic address: https://twitter.com/RobertAriens.
Zitieren
APA
Connors, J. M., & Ariëns, R. A. S. (2024). Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.11.005
Vancouver
Connors JM, Ariëns RAS. Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.11.005
BibTeX
@article{Connors2024,
author = {Connors, Jean M and Ariëns, Robert A S},
title = {Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2023.11.005}
}
EUVIMED